Literature DB >> 9601114

Cervical and breast cancer screening in wheelchair dependent females.

A Graham1, G Savic, B Gardner.   

Abstract

The aim of this study was to compare the attendance rates for cervical and breast cancer screening in wheelchair dependent spinal cord injured (SCI) women with those in the general female population in England. The study was conducted as a postal questionnaire survey with an effective response rate of 79%. The attendance rates of the eligible SCI groups were 84% for cervical screening and 72% for mammography, both figures being well within the national average attendance rates in the general female population. Difficulties with cervical screening were reported in 58% and with mammography in 43% of the cases, including restricted access to clinics, examining rooms and examining couches and positioning during the procedure. These were also the main reasons given for non attendance. The article points out ways to enable even more wheelchair dependent women to benefit from the preventative screening programmes.

Entities:  

Mesh:

Year:  1998        PMID: 9601114     DOI: 10.1038/sj.sc.3100613

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  3 in total

1.  Spinal cord injured women's treatment of breast carcinoma: alert to complications.

Authors:  Ashley L de Padua; Kimberly Strickland; Mary Patrick; John F Ditunno
Journal:  Spinal Cord Ser Cases       Date:  2018-05-23

2.  Barriers to accessing cancer services for adults with physical disabilities in England and Wales: an interview-based study.

Authors:  Dikaios Sakellariou; Sally Anstey; Sarah Gaze; Eleri Girt; Daniel Kelly; Barbara Moore; Sarah Polack; Roger Pratt; Gill Tyrer; Narelle Warren; Wendy Wilkinson; Molly Courtenay
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

3.  Disability and participation in breast and bowel cancer screening in England: a large prospective study.

Authors:  S Floud; I Barnes; M Verfürden; H Kuper; T Gathani; R G Blanks; R Alison; J Patnick; V Beral; J Green; G K Reeves
Journal:  Br J Cancer       Date:  2017-10-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.